Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 3/20 | 0.74 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.74 |
| ▸ | MAOB | P27338 | 2/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.74 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.74 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.74 |
| ▸ | IAPP | P10997 | 1/20 | 0.66 |
| ▸ | TYR | P14679 | 3/20 | 0.61 |
| ▸ | F3 | P13726 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | CA7 | P43166 | 3/20 | 0.61 |
| ▸ | CA9 | Q16790 | 3/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9735291 | 1.00 | AKR1B1 (0.74) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL428638 | 0.85 | AKR1B1 (1.00) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL2574140 | 0.85 | AKR1B1 (1.00) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL19236353 | 0.85 | IAPP (0.70) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL22328172 | 0.84 | RAB9A (0.66) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| Bisdemethoxycurcumin SCHEMBL28163045 | 0.83 | AKR1B1 (0.96) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL27699740 | 0.82 | CYP1A2 (0.62) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL22214054 | 0.82 | IAPP (0.59) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL3401728 | 0.82 | HSD11B1 (0.62) | AKR1B1AKR1B10MAOBPTGS2GLO1 | |
| SCHEMBL3401725 | 0.82 | HSD11B1 (0.62) | AKR1B1AKR1B10MAOBPTGS2GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2847318-B1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | MARRONE BIO INNOVATIONS INC (US) | 2019-01-23 | — | — | EP | claimed |
| US-20250011293-A1 | LEUKOTRIENE SYNTHESIS INHIBITORS | NAEGIS PHARMACEUTICALS INC. (CA) | 2025-01-09 | — | — | US | disclosed |
| US-11976052-B2 | Leukotriene synthesis inhibitors | NAEGIS PHARMACEUTICALS INC. (CA) | 2024-05-07 | — | — | US | disclosed |
| US-20220064132-A1 | LEUKOTRIENE SYNTHESIS INHIBITORS | NAEGIS PHARMACEUTICALS INC. (CA) | 2022-03-03 | — | — | US | disclosed |
| US-20210227833-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2021-07-29 | — | — | US | disclosed |
| US-11013236-B2 | Pesticidal Flavobacterium strain and bioactive compositions metabolites and uses | MARRONE BIO INNOVATIONS, INC. (US) | 2021-05-25 | — | — | US | disclosed |
| US-11013236-B2 | Pesticidal Flavobacterium strain and bioactive compositions metabolites and uses | MARRONE BIO INNOVATIONS, INC. (US) | 2021-05-25 | — | — | US | disclosed |
| EP-2847318-B1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | MARRONE BIO INNOVATIONS INC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | PRO FARM GROUP, INC. | 2015-01-29 | — | — | US | disclosed |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | PRO FARM GROUP, INC. | 2015-01-29 | — | — | US | disclosed |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | PRO FARM GROUP, INC. | 2015-01-29 | — | — | US | disclosed |
| WO-2013138398-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2013-09-19 | — | — | WO | disclosed |
| US-5135955-A | Anticoagulants or antifungal activity | ELI LILLY AND COMPANY (US) | 1992-08-04 | — | — | US | disclosed |
| EP-0339878-A2 | Propanamine derivatives | ELI LILLY AND COMPANY (US) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064132-A1 | LEUKOTRIENE SYNTHESIS INHIBITORS | LTC4S, LTB4R2, LTA4H | AKR1B1 619/4885AKR1B10 654/4885MAOB 758/4885 |
| US-20210227833-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | BLVRB, PRDX6, ACHE | AKR1B1 2910/4885AKR1B10 3354/4885MAOB 224/4885 |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | BLVRB, PRDX6, ACHE | AKR1B1 2910/4885AKR1B10 3354/4885MAOB 224/4885 |
| US-11013236-B2 | Pesticidal Flavobacterium strain and bioactive compositions metabolites and uses | BLVRB, PRDX6, ACHE | AKR1B1 2910/4885AKR1B10 3354/4885MAOB 224/4885 |
| US-11976052-B2 | Leukotriene synthesis inhibitors | LTC4S, LTB4R2, LTA4H | AKR1B1 619/4885AKR1B10 654/4885MAOB 758/4885 |
| US-20250011293-A1 | LEUKOTRIENE SYNTHESIS INHIBITORS | LTC4S, LTB4R2, LTA4H | AKR1B1 619/4885AKR1B10 654/4885MAOB 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.